“B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2 ADM”. Journal of Cancer Research Updates 3, no. 1 (January 2, 2014):  59–66. Accessed August 19, 2026. https://www.neoplasiaresearch.com/index.php/jcru/article/view/550.